enGene logo

enGene

ENGN | NASDAQ
Chart Builder DCF Calculator
$1.72
-$0.17 (-8.99%)
At close: Nov 17, 2026, 4:00 PM ET
$1.87
+$0.15 (+8.70%)
After-hours: Nov 17, 2026, 7:47 PM ET
-8.99%

Rating

Updated: Nov 17, 2026
29.5
+1.5 pts
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #798/1014 (Top 79%)

Key Statistics

Market Data

Market Cap $115.27M
1D Range
1.68 1.94
52W Range
1.44 12.17

Valuation (TTM)

PE -6.14
PB 0.50
EV/EBITDA 0.89

Valuation (NTM)

Forward PE N/A
Forward PEG N/A
Price Target $4.00
Loading financial charts...

Profile

Operating through its subsidiary, enGene, Inc., enGene Holdings Inc. functions as a clinical-stage biotechnology firm. Its core mission involves pioneering genetic pharmaceuticals, achieved by adminis...

Sector Healthcare
Industry Biotechnology
Employees 82
IPO Date Feb 1, 2022
Fiscal Year November - October

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
8
Consensus
Hold
Price Target
$4.00
Upside
+132.56%
Buy (4)
Hold (3)
Sell (1)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.